Comprehensive Biosciences · Wharton's Jelly
WJ Acellular
WJ+ with the live cells removed, keeping the growth factors, hyaluronic acid, exosomes, and ECM proteins. A cell-free option for non-IV procedures.
Product illustration. Photos available on request. Actual packaging may differ.
Comprehensive Biosciences
WJ+ Wharton's Jelly
A concentrated umbilical cord Wharton's Jelly product with live cells kept in the native Wharton's Jelly matrix. For non-IV procedures only.
Part of the biologics line. Compare all 11 products by type, format, and storageLicensed providers · HCT/P. Human tissue product. Sold only to licensed providers; use per the manufacturer's IFU.
Common in: Orthopedics & sports medicine · Pain management · Regenerative medicine
Key facts
- 1 mL (WJ+ 2100) and 2 mL (WJ+ 2200)
- Manufacturer recommends mixing 1:1 with Bio Scaffolding for local procedures
- Not for IV or intranasal use
Downloads & documents
Specifications
| Per 1 mL (approx.) | ~2 million total viable nucleated cells · ~260,000 MSCs · ~360,000 EPCs · ~100 million exosomes |
|---|---|
| Tissue solids | ~260 mg per mL |
| Sizes | 1 mL · 2 mL |
From Comprehensive Biosciences materials. Confirm current specs and IFU before use.
About Comprehensive Biosciences
Biotechnology company founded in 2022 and led by Dr. Charles Sly and Dr. Roy Korth, with patented methods for isolating serum components and perinatal tissue. Its birth-tissue line comes from a manufacturer-owned, FDA-registered tissue bank: Wharton's Jelly, exosomes, Muse cell products, cord blood plasma extract, and Bio Scaffolding.
Related products
Compare all biologics
VitaCell Bio Global · Wharton's Jelly
VitaCell & VitaCell Pro Wharton's Jelly
Wharton's Jelly allografts from umbilical cords donated by consenting mothers. The two versions use the same processing and differ only in concentration.